Biology Reference
In-Depth Information
Kallas, A., Pook, M., Maimets, M., Zimmermann, K., & Maimets, T. (2011). Nocodazole
treatment decreases expression of pluripotency markers Nanog and Oct4 in human
embryonic stem cells.
PLoS One
,
6
, e19114.
Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., et al. (2009).
Linking the p53 tumour suppressor pathway to somatic cell reprogramming.
Nature
,
460
,
1140-1144.
Kimura, H., Tada, M., Nakatsuji, N., & Tada, T. (2004). Histone code modifications on
pluripotential nuclei of reprogrammed somatic cells.
Molecular and Cellular Biology
,
24
,
5710-5720.
King, T. J., & Briggs, R. (1955). Changes in the nuclei of differentiating gastrula cells, as
demonstrated by nuclear transplantation.
Proceedings of the National Academy of Sciences
of the United States of America
,
41
, 321-325.
Lange, C., Huttner, W. B., & Calegari, F. (2009). Cdk4/cyclinD1 overexpression in neural
stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion
of basal progenitors.
Cell Stem Cell
,
5
, 320-331.
Lemaitre, J. M., Danis, E., Pasero, P., Vassetzky, Y., & M´chali, M. (2005). Mitotic remo-
deling of the replicon and chromosome structure.
Cell
,
123
, 787-801.
Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Ca˜amero, M., et al. (2009). The
Ink4/Arf locus is a barrier for iPS cell reprogramming.
Nature
,
460
, 1136-1139.
Lin, T., Chao, C., Saito, S., Mazur, S. J., Murphy, M. E., Appella, E., et al. (2005). p53
induces differentiation of mouse embryonic stem cells by suppressing Nanog expression.
Nature Cell Biology
,
7
, 165-171.
Mari´n, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., et al. (2009). A p53-
mediated DNA damage response limits reprogramming to ensure iPS cell genomic integ-
rity.
Nature
,
460
, 1149-1153.
Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofemeister, H., et al. (2012).
The transcriptional and epigenomic foundations of ground state pluripotency.
Cell
,
149
,
590-604.
Martin, G. R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured
in medium conditioned by teratocarcinoma stem cells.
Proceedings of the National Academy
of Sciences of the United States of America
,
78
, 7634-7638.
Mayshar, Y., Ben-David, U., Lavon, N., Biancotti, J. C., Yakir, B., Clark, A. T., et al.
(2010). Identification and classification of chromosomal aberrations in human induced
pluripotent stem cells.
Cell Stem Cell
,
7
, 521-531.
McNairn, A. J., & Gilbert, D. M. (2003). Epigenomic replication: Linking epigenetics to
DNA replication.
Bioessays
,
25
, 647-656.
Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., et al. (2008).
Dissecting direct reprogramming through integrative genomic analysis.
Nature
,
454
,
49-55.
Miller, R. A., & Ruddle, F. H. (1976). Pluripotent teratocarcinoma-thymus somatic cell
hybrids.
Cell
,
9
, 45-55.
Neganova, I., Zhang, X., Atkinson, S., & Lako, M. (2009). Expression and functional analysis
of G1 to S regulatory components reveals an important role for CDK2 in cell cycle reg-
ulation in human embryonic stem cells.
Oncogene
,
28
, 20-30.
Niehrs, C. (2009). Active DNA demethylation and DNA repair.
Differentiation
,
77
, 1-11.
Niehrs, C., & Sch
¨
fer, A. (2012). Active DNA demethylation by Gadd45 and DNA repair.
Trends in Cell Biology
,
22
, 220-227.
Niwa, H. (2007). How is pluripotency determined and maintained?
Development
,
134
,
635-646.
Ohtsuka, S., & Dalton, S. (2008). Molecular and biological properties of pluripotent embry-
onic stem cells.
Gene Therapy
,
15
, 74-81.
